January 29, 2009 - Medusa Medical Technologies Inc.’s flagship electronic patient care reporting software, the Siren ePCR Suite, now has an interface with the Philips HeartStart MRx monitor/defibrillator.

January 29, 2009 - Epocrates Inc. has introduced its Epocrates Essentials suite for the iPhone and iPod Touch operating systems, which expands upon the company's popular free drug guide to include disease and diagnostic resources.

January 29, 2009 - GE Healthcare's Vascular Ultrasound group and The Medipattern Corp. said they are collaborating on the creation of Ultrasound-based Vascular Imaging Quantification Tools (Vascular iQ).

January 28, 2009 - Philips is leading a major new European project, the SonoDrugs project, which uses focused ultrasound pulses and magnetic resonance imaging (MRI) to deliver and track therapeutic drugs used to treat cancer and cardiovascular disease, in hopes of maximizing efficiency and minimizing side effects.

January 28, 2009 - Australian-based Pro Medicus Limited said today it has acquired Visage Imaging, a digital imaging and advanced 3D visualization technology based in Carlsbad, CA.

January 28, 2009 - Attended by over 40 cardiothoracic surgeons, Cardiogenesis Corp.'s education symposium at the recent Society of Thoracic Surgeons Meeting in San Francisco was entitled "Advancements in Revascularization & Stem Cell Therapy."

January 28, 2009 - Boston Scientific Corp. and Medtronic Inc. today announced the settlement of two lawsuits and an agreement to stand down in three others.

These agreements stop all current litigation between the two parties in the fields of interventional cardiology and endovascular repair. All the disputes involved intellectual property.

January 28, 2009 – Under the terms of a newly penned seven-year agreement, LeMaitre Vascular has earned exclusive rights to market and sell certain sizes of Neovasc Inc.’s biological vascular strip for use in vascular surgery procedures in the U.S. and Europe.

January 28, 2009 - SurModics Inc. and Nexeon MedSystems Inc. this week signed a licensing agreement to collaborate on development of a novel stent system for the treatment of renal artery disease.

This agreement is in addition to the prior one announced in July 2007 to develop a novel stent system for coronary artery disease, which is now in clinical trials. SurModics is also an equity investor in Nexeon MedSystems.

January 28, 2009 - The AF Summit returns this year during Heart Rhythm 2009, set for May 13-16 in Boston, after a sold-out event at Heart Rhythm 2007.

This one-and-a-half-day summit will highlight the latest advances in atrial fibrillation and including a jointly sponsored session with the American Association for Thoracic Surgery (AATS).

The sessions on Wednesday, May 13 will cover pushing the envelope of scientific and personal discovery, ablative intervention in 2010, ablation vs. surgery for AF and a keynote by Dr. J. Craig Venter.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now